Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2007
10/18/2007WO2007098417A3 Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
10/18/2007WO2007095613A3 Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
10/18/2007WO2007065713B1 Use of 8-alpha-ergolines for the treatment of traumatic brain disorders
10/18/2007WO2007063509A3 Phosphocreatine complexes
10/18/2007WO2007045243A3 Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1
10/18/2007WO2006055964A3 Zolmitriptan crystal forms
10/18/2007US20070244194 Carboxamido opioid compounds
10/18/2007US20070244186 cdc25 tyrosine phosphatase inhibitors such as 5-{[2-(dimethylamino)ethyl]amino}-2-(morpholin-4-ylcarbonyl)-1,3-benzothiazole-4,7-dione, used as anticarcinogenic agents
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244161 Novel mercaptophenyl naphthyl methane compounds and synthesis thereof
10/18/2007US20070244149 Tropane analogs and methods for inhibition of monoamine transport
10/18/2007US20070244147 Therapeutic agent for schizophrenia
10/18/2007US20070244145 Cyclic Amine Compound
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors
10/18/2007US20070244109 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
10/18/2007US20070244102 Combination of Dermaciclane and Opoids as Analgesics
10/18/2007US20070244100 Derivatives of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic Acid and Methods of Making Them
10/18/2007US20070244099 Such as 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amide; calcitonin gene related peptide (CGRP); for treatment of migraines; radioimmunoassay
10/18/2007US20070244097 Nicotinic AcetylcholineReceptor Ligands
10/18/2007US20070244057 Suppressing polyglutamine aggregation and toxicity
10/18/2007US20070244056 Combination Therapy With Glatiramer Acetate and Riluzole
10/18/2007US20070244039 Therapeutic agent composition and method of use
10/18/2007US20070243609 Cell populations which co-express CD49c and CD90
10/18/2007US20070243254 Novel drug compositions and dosage forms of topiramate
10/18/2007US20070243226 Growth factor complex
10/18/2007US20070243160 Remedies for nerve damages
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/18/2007DE102006017827A1 Neue kristalline Verbindungen New crystalline compounds
10/18/2007DE102006016991A1 Verwendung von kappa-Opioidrezeptor-Antagonisten zur Behandlung von dissoziativen Störungen The use of kappa opioid receptor antagonists for the treatment of dissociative disorders
10/18/2007DE102006016990A1 Verwendung von Baclofen und Baclofen-Derivaten zur Entzugs- und/oder Substitutionsbehandlung bei Abhängigkeit von GHB und/oder GHB-Analogen Use of baclofen and baclofen derivatives for the withdrawal and / or substitution treatment when dependent on GHB and / or GHB analogs
10/18/2007CA2683064A1 Trimetazidine for use in the treatment of fibromyalgia syndrome and related conditions
10/18/2007CA2648943A1 Mazindol combination in the treatment of attention deficit/hyperactivity
10/18/2007CA2648914A1 Pyridyloxadiazole substituted compounds and compositions
10/18/2007CA2648330A1 Anti-ccr2 antibody depletes monocytes to treat multiple sclerosis and rheumatoid arthritis
10/18/2007CA2648168A1 Heterocyclic gaba alpha subtype selective receptor modulators
10/18/2007CA2648055A1 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/18/2007CA2647903A1 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
10/18/2007CA2647246A1 Stimulation of neuron regeneration by secretory leukocyte protease inhibitor
10/18/2007CA2646917A1 Novel sulfonamide compounds
10/18/2007CA2646899A1 Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders
10/18/2007CA2643633A1 The use of an antibody directed against beta amyloid peptide for the treatment of alzheimer's disease
10/17/2007EP1845098A1 Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
10/17/2007EP1845097A1 Oxadiazole derivatives as COMT inhibitors
10/17/2007EP1845092A1 Pyrimidinone compounds, their preparation and use thereof
10/17/2007EP1845089A1 Novel lactams and uses thereof
10/17/2007EP1845084A1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomethylcyclopropane
10/17/2007EP1845081A1 Amide compound
10/17/2007EP1844784A1 A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
10/17/2007EP1844783A1 Use of 4,9-anhydro-tetrodotoxin for the treatment of diseases related to the voltage-gated sodium channel - subunit Nav1.6
10/17/2007EP1844782A1 Use of 4,9-anhydro-tetrodotoxin for the treatment of diseases related to the voltage-gated sodium channel subunit Nav1.6
10/17/2007EP1844779A2 Tergurid/protergurid for treating chronic pain (e.g. migraine)
10/17/2007EP1844777A1 Chronic, bolus administration of d-treo methylphenidate
10/17/2007EP1844774A2 A pharmaceutical composition for angiotensin II-mediated diseases
10/17/2007EP1844769A2 Methods for treating neuropsychiatric disorders
10/17/2007EP1844047A1 Hydrate of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]- pyramidin-7-yl}phenyl)acetamide and processes and methods related thereto
10/17/2007EP1844044A1 Thiazole-4-carboxamide derivatives as mglur5 antagonists
10/17/2007EP1844035A1 Amino-pyridines as inhibitors of beta-secretase
10/17/2007EP1844034A1 Dnt-fumarate and methods of preparation thereof
10/17/2007EP1844030A1 Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists
10/17/2007EP1844017A1 An amorphous and three crystalline forms of rimonabant hydrochloride
10/17/2007EP1844016A1 Polymorph and solvates of aripiprazole
10/17/2007EP1844000A1 Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
10/17/2007EP1843774A1 Pulsatilla spp. extracts effective in brain function
10/17/2007EP1843769A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
10/17/2007EP1843767A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders.
10/17/2007EP1843762A1 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
10/17/2007EP1843760A1 Classes of compounds that interact with integrins
10/17/2007EP1843757A1 Phantom phenomena treatment
10/17/2007EP1843661A2 Compositions comprising o-acetylsalicyl derivatives of aminocarbohydrates and amino acids
10/17/2007EP1646393A4 A stable clozapine suspension formulation
10/17/2007EP1492540B1 The use of devazepide as analgesic agent
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines
10/17/2007EP1392713B1 Liver x receptor agonists
10/17/2007EP1372638A4 Functional role for cannabinoids in autonomic stability during sleep
10/17/2007EP1315505B1 Pharmaceutical compositions for headache, migraine, nausea and emesis
10/17/2007EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007EP1173432B1 Piperidine-indole compounds having 5-ht6 affinity
10/17/2007EP1141728B1 Kidney disease detection and treatment
10/17/2007EP1102758B1 Particle-forming compositions containing fused pyrrolocarbazoles
10/17/2007EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
10/17/2007EP0993613B8 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
10/17/2007EP0970195B1 Fatty-acid amide hydrolase
10/17/2007CN101056890A Deamidated interferon-beta
10/17/2007CN101056867A Process for production of optically active amine derivatives
10/17/2007CN101056859A Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand
10/17/2007CN101056637A Pharmaceutical composition for transdermal administration of perospirone
10/17/2007CN101056631A Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
10/17/2007CN101056627A Therapeutic agent for interstitial cystitis
10/17/2007CN101054572A Method for cultivating human umbilical blood stem cell and directionally differentiating the same to dopaminergic nerve cell and application for the obtained dopaminergic nerve cell
10/17/2007CN101054400A Novel Panoxadiol and derivative, preparation method and medical use thereof
10/17/2007CN101054364A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (ER) ligands and their use in the treatmentof inflammarory diseases
10/17/2007CN101054363A Huperzine A derivative, preparation method and application thereof
10/17/2007CN101054346A Preparation method and use for a set of novel compound and composition thereof
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053635A 'Duyinxiao'
10/17/2007CN101053623A Medicinal composition for treating pain and preparation technology thereof
1 ... 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 ... 1833